apiLogger::2021-11-04 14:49:35,859::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-04 14:49:35,867::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-04 14:49:35,868::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmplihnyf8u 
apiLogger::2021-11-04 14:49:35,869::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-04 14:49:35,869::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-04 14:49:35,904::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-04 14:49:35,904::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmplihnyf8u
apiLogger::2021-11-04 14:49:36,649::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-04 14:49:36,649::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-04 14:49:36,651::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-04 14:49:36,651::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-04 14:49:36,658::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-04 14:49:36,658::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-04 14:49:36,658::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-04 14:49:36,658::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-11-04 14:49:36,663::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-04 14:49:36,663::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-11-04 14:49:36,663::content_type.py::(line:178)::find_content_type()::DEBUG : outside:2
apiLogger::2021-11-04 14:49:36,663::content_type.py::(line:131)::find_content_type()::DEBUG : i is 2
apiLogger::2021-11-04 14:49:36,667::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-04 14:49:36,667::content_type.py::(line:134)::find_content_type()::DEBUG : main: 2
apiLogger::2021-11-04 14:49:36,667::content_type.py::(line:178)::find_content_type()::DEBUG : outside:3
apiLogger::2021-11-04 14:49:36,667::content_type.py::(line:131)::find_content_type()::DEBUG : i is 3
apiLogger::2021-11-04 14:49:36,670::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-04 14:49:36,671::content_type.py::(line:134)::find_content_type()::DEBUG : main: 3
apiLogger::2021-11-04 14:49:36,671::content_type.py::(line:178)::find_content_type()::DEBUG : outside:4
apiLogger::2021-11-04 14:49:36,671::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 1 of 4\nCase ID: REGEMC-106162 (v.3)\nA. GENERAL INFORMATION\nCase Number: REGEMC-106162 Report Version: 3\nEVERSANA Received Date: 03-Nov-2021 12:45, Version 3 Source: Email\nEVERSANA Staff: Nadine Baker, Pharm.D. Attachments Included:\nReference ID #: Reference/Patient ID: RE00R0Z0 \nB. CONTACT/REPORTER INFORMATION\nReporter Name: Ms. Pamela S. Patterson Reporter Type: Company Representative\nTitle: Patient Access Specialist\nAddress: Lash Group Phone: 803-228-5100 (ext. 2015014)\n1799 Innovation Point Other Phone:\nFort Mill, SC 29715 Fax:\nUNITED STATES Email: Pamela.Patterson2@lashgroup.com\nPrimary Reporter:  Yes     No\nC. ADDITIONAL CONTACT DETAILS\nInitial notification received from    Yes     No (specify):\nprimary reporter:  Pamela Patterson EYLEA-4-U, 803-228-5100 (ext. 2015014), Pamela.Patterson2@lashgroup.com\nReceived date: : 15-Oct-2021, Version 3\nWas a corresponding PC report   Yes     No\nfiled:\nPrimary Reporter Reported to  Unk\nAgency?\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 2 of 4\nCase ID: REGEMC-106162 (v.3)\nD. ADVERSE EVENT DETAILED DESCRIPTION\nCompletion Instruction: \nThis should be a detailed and accurate transcription of the call.  As much as possible, record the caller’s description of the event verbatim and without \nparaphrasing.  Additional comments from the person taking the call should be documented as well and clearly reflected as such (i.e., Call Center \ncomment). Details on the purpose of call, exposure to RGN product (i.e., therapy start and stop dates, including interruptions), course of the adverse \nevent (i.e., treatment, worsening or improvement in symptoms) are critical to the meaningful assessment of this report.  All questions on this form \nmust be asked during the call.  Any questions omitted or not asked due to other reasons (i.e., caller hung up) should be noted here.\nOccur Country: UNITED STATES\nOn 15-Oct-2021, Regeneron Medical Information received the following event report via email from the Eylea4U LASH Group:\n"1.       Possible Adverse drug exposure to EYLEA- Deceased Patient\n2.       Exposure to EYLEA (UNKNOWN)\n3.       Name, Address, telephone number of the reporter: Maria Shafer  Central Florida Retina- Orlando 3824 Oakwater Circle Orlando, FL 32806 \nPH: (407) 425-7188/ Fax: (407) 278-4008\n4.       Patient Information:  J. B./ Male/ 65\n5.       Patient unique record ID from the Lash Database: RE00R0Z0\n6.       Patient Diagnosis Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization\n7.       Physicians Name, Site Name, Address, Phone/Fax number: Gokul Kumar, MD Central Florida Retina- Orlando 3824 Oakwater Circle \nOrlando, FL 32806 PH: (407) 425-7188/ Fax: (407) 278-4008\n8.       Consent to contact the physician or the patient (Unknown)\n9.       Is patient being reported as deceased?:   YES  \na.       What are the dates of first and last injection? (Unknown)\nb.       Total # of injections  (Unknown)\nc.       Date of Death (Unknown)\nd.       Cause of death (Unknown)\ne.       If death was related to EYLEA therapy (Unknown)\nf.        How was date of death discovered: Fax from the site "\nPlease refer to the enclosed source document for additional information.\nNo further information was available at the time of this report.\nVERSION 2 (NBaker):\nThis version has been created by Regeneron Medical Information to transmit Regeneron Global Patient Safety paperwork received via fax on 02-\nNov-2021. Please refer to the enclosed source document for additional information. No further information was available at the time of this \nreport.\nVERSION 3 (NBaker):\nThis version has been created by Regeneron Medical Information to transmit Regeneron Global Patient Safety paperwork received via fax on 03-\nNov-2021. Please refer to the enclosed source document for additional information. No further information was available at the time of this \nreport.\nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 3 of 4\nCase ID: REGEMC-106162 (v.3)\nE. PATIENT INFORMATION\nPatient Contact Info \nAvailable?\nPatient Name,  Permission to contact \nJB\nInitials: patient for HCP info?\nAddress: Phone:\nDOB Fax:\nAge: Gender:\nHeight: Weight\nF. SUSPECT PRODUCTS\n(For Eylea) Needle Gauge:\nIf applicable, Eylea NOS \nClarification:\nStart Date Dose, Units\nStop Date Frequency Indication Batch #\nProduct  Ongoing Admin Route Action Taken Expiry Date\nEylea NOS  \nF. CONCOMITANT PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nF. HISTORICAL PRODUCTS\nStart Date Dose, Units\nStop Date Frequency\nProduct  Ongoing Admin Route\n \nG. OTHER RELEVANT HISTORY, INCLUDING PREEXISTING MEDICAL CONDITIONS\nH. RELEVANT TESTS/LABORATORY DATA, INCLUDING DATES \nI. PROVIDER INFORMATION & CONSENT DETAILS\nPhone\nOther Phone Consent Provided, \nProvider Organization & Address Fax Email on Date Notes\n \n \nVersion 16Nov2020 Regeneron Pharmaceuticals, Inc.\nADVERSE EVENT FORM Page 4 of 4\nCase ID: REGEMC-106162 (v.3)\nVersion 16Nov2020']
apiLogger::2021-11-04 14:49:36,671::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-11-04 14:49:36,671::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-04 14:49:36,978::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-04 14:49:36,985::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-04 14:49:36,986::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp2bpavtvm 
apiLogger::2021-11-04 14:49:37,181::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-04 14:49:37,188::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-04 14:49:37,188::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpx01m4d9m 
apiLogger::2021-11-04 14:49:37,493::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-04 14:49:37,496::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-04 14:49:37,502::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpae0pz5bu 
apiLogger::2021-11-04 14:49:37,766::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-04 14:49:37,767::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-04 14:49:37,806::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpmiymcdvc 
apiLogger::2021-11-04 14:49:37,806::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-04 14:49:37,806::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-04 14:49:37,813::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-04 14:49:37,813::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpmiymcdvc
apiLogger::2021-11-04 14:49:37,883::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-04 14:49:37,883::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-04 14:49:37,883::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-04 14:49:37,883::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-04 14:49:37,888::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-04 14:49:37,888::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-04 14:49:37,888::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-04 14:49:37,888::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : Marc Lamberti-External <marc.lamberti@regeneron.com>\nReceived Date : 04-Nov-2021 14:48:43 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Regeneron Adverse Event Report for Eylea NOS: REGEMC-106162 Version 3\nEXTERNAL MESSAGE\n \n \nAttached please find a Regeneron Adverse Event report regarding Eylea NOS received by\nEVERSANA™ Life Science Services.  \n \nThe reference number for this report is REGEMC-106162, Version 3.\n \n******************************************************************************************\nInstructions for Regeneron to acknowledge receipt of this report:\n \nCLICK HERE and send the e-mail which is generated.\n \n******************************************************************************************\n \nIf you have any questions or comments, please contact me.\n \nThank you.\n \nNadine Baker, Pharm.D.\nEVERSANA™ Life Science Services \n2200 Powell Street\nSuite 800\nEmeryville, CA 94608\nDo not edit anything after this #[[#A5EAD037-7A8B-4160-A401-7A841146E3A5#]]# \nIMPORTANT NOTICE:  The information contained in this communication is for the sole use of the\nintended recipient(s) and may contain confidential information. If you are not an intended recipient\n, you are hereby notified that any use, disclosure, copying or distribution of this communication or\nits contents is strictly prohibited. If you have received this communication in error, please contact\nthe sender immediately and delete the original message and any copies from your computer\nsystem.']
apiLogger::2021-11-04 14:49:37,888::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-11-04 14:49:37,888::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 09:07:57,362::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 09:07:57,368::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 09:07:57,369::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp8f11m2uo 
apiLogger::2021-11-05 09:07:57,370::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 09:07:57,370::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 09:07:57,395::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 09:07:57,395::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp8f11m2uo
apiLogger::2021-11-05 09:07:57,425::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 09:07:57,425::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 09:07:57,426::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 09:07:57,426::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 09:07:57,430::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-05 09:07:57,431::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 09:07:57,431::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-05 09:07:57,431::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'Test Data for PVIT scenario 14 ']
apiLogger::2021-11-05 09:07:57,431::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-11-05 09:07:57,431::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 09:07:58,038::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 09:07:58,039::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 09:07:58,039::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpru7zoe1c 
apiLogger::2021-11-05 09:07:58,040::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 09:07:58,040::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 09:07:58,046::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 09:07:58,046::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpru7zoe1c
apiLogger::2021-11-05 09:07:58,079::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 09:07:58,080::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 09:07:58,080::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 09:07:58,080::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 09:07:58,084::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-05 09:07:58,084::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 09:07:58,084::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-05 09:07:58,084::pvi_api.py::(line:221)::main_function()::DEBUG : ['UNKNOWN', 'UNKNOWN', 'From : David Jennings <david.jennings@regeneron.com>\nReceived Date : 05-Nov-2021 09:06:37 +0000\nTo : "Medsaf.dev3" <Medsaf.dev3@regeneron.com>\nSubject : Scenario 14 David Jennings\nScenario 14 \n \n05 Nov 2021 \n \n \n \nDavid Jennings, BSc \nAssociate Director, GPS Case Evaluation and Reporting Management\nRegeneron Pharmaceuticals Inc. \nUK Uxbridge \n \nEmail: David.Jennings@Regeneron.com \nMobile: (+44) 07585 550363 \n \nREGENERON\n  SCIENCE TO MEDICINE® \nRegeneron Pharmaceuticals Inc.\n777 Old Saw Mill River Road, Tarrytown, NY 10591 \n ']
apiLogger::2021-11-05 09:07:58,085::pvi_api.py::(line:236)::main_function()::INFO : content type is unkown and form may goes to unstructured
apiLogger::2021-11-05 09:07:58,085::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 13:07:39,917::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 13:07:39,923::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 13:07:39,923::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpba0lk8za 
apiLogger::2021-11-05 13:07:39,924::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 13:07:39,924::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 13:07:40,063::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 13:07:40,063::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpba0lk8za
apiLogger::2021-11-05 13:07:42,977::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 13:07:42,977::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 13:07:42,977::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 13:07:42,977::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 13:07:42,982::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-05 13:07:42,982::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 13:07:42,982::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-05 13:07:42,982::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-11-05 13:07:42,986::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-11-05 13:07:42,986::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-11-05 13:07:42,986::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-11-05 13:07:42,986::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-11-05 13:07:42,987::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-11-05 13:07:42,987::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-11-05 13:07:42,987::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-11-05 13:07:42,987::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-11-05 13:07:42,987::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-11-05 13:07:42,987::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-11-05 13:08:01,978::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-11-05 13:08:01,978::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 14:47:52,666::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 14:47:52,695::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 14:47:52,695::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpxsj41ge5 
apiLogger::2021-11-05 14:47:52,696::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 14:47:52,696::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 14:47:53,132::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 14:47:53,132::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpxsj41ge5
apiLogger::2021-11-05 14:47:56,465::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 14:47:56,465::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 14:47:56,465::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 14:47:56,465::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 14:47:56,469::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeREGN_1625
apiLogger::2021-11-05 14:47:56,470::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 14:47:56,470::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-11-05 14:47:56,470::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 0
apiLogger::2021-11-05 14:47:56,470::pvi_api.py::(line:221)::main_function()::DEBUG : ['REGN_1625', 'generic', 'REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nProject Details\nProtocol Number R1979-ONC-1625 \nAN OPEN-LABEL STUDY TO ASSESS THE ANTI-TUMOR ACTIVITY AND\nSAFETY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC\nProtocol Title\nANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL\nNON-HODGKIN LYMPHOMA\ninVentiv Health Study Code 17RGP-0008\nCompound REGN1979\nSubject Details\nSite Name 840027 - Ayyappan - US\nSite Number 1625840027\nSubject ID: 84002700273\nScreening Date 16 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nInformed Consent and Protocol Amendment Tracking\nInformed Consent Date subject signed\nWere there any Date Subject Signed\nGlobal Protocol ;  Amendment Protocol IRB Approval date ICF Approval date from local Informed\n# local Informed Consent Consent Type\nAmendment Version Version (Local)  (dd-mon-yyyy) Version EC/IRB (dd-mon- Consent (dd-mon-\namendments? (dd-mon-yyyy)\nyyyy) yyyy), if applicable\nR1979-ONC-1625\n1 17 AUG 2021 Main consent 04 AUG 2021 17 AUG 2021\nAmendment 4 Global\nDemography Details\nRace, If Other-\nSubject Name Year of Birth Age Sex Ethnicity Race\nSpecify\n840027002 1957 63 Female - - -\nDisease-Specific Cohort\nDisease specific cohort/group (integrated) DLBCL Selected Regimen REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nMedical History\nDate\nIf ongoing\nStart Date Check for resolved Check for\nMedical History /Finding Ongoing at specify\n# (dd-mon- unknown start (End date) unknown end\n(Abnormality) study entry? CTCAE\nyyyy) date (dd-mon- date\nGrade\nyyyy)\n1 HYPERLIPIDEMIA 1 MAY 2020 unchecked Ongoing Grade 2 - unchecked\n2 HYPERCALCEMIA 12 AUG 2021 unchecked Resolved - 17 AUG 2021 unchecked\n3 HYPERTENSION 21 NOV 2016 unchecked Ongoing Grade 2 - unchecked\n4 PALPITATIONS 17 JUN 2020 unchecked Ongoing Grade 1 - unchecked\n5 INCREASED CREATININE 23 NOV 2020 unchecked Ongoing Grade 1 - unchecked\n6 THROMBOCYTOPENIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\n7 ANEMIA 12 AUG 2021 unchecked Ongoing Grade 3 - unchecked\nINTERMITTENT\n8 06 SEP 2020 unchecked Ongoing Grade 1 - unchecked\nHYPOKALEMIA\nINTERMITTENT\n9 17 AUG 2021 unchecked Ongoing Grade 2 - unchecked\nHYPOPHOSPHATEMIA\n10 COUGH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n11 SHORTNESS OF BREATH 12 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT FLUID\n12 19 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nOVERLOAD\nINTERMITTENT\n13 17 AUG 2020 unchecked Ongoing Grade 1 - unchecked\nHEADACHES\n14 PERIPHERAL NEUROPATHY UN UNK 2019 unchecked Ongoing Grade 1 - unchecked\n15 DIARRHEA 19 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nINTERMITTENT\n16 UN AUG 2020 unchecked Ongoing Grade 1 - unchecked\nTACHYCARDIA\n17 INSOMNIA 17 AUG 2021 unchecked Ongoing Grade 1 - unchecked\n18 FEVER 15 AUG 2021 unchecked Ongoing Grade 1 - unchecked\nHYPOGAMMAGLOBULINEMI\n19 19 APR 2021 unchecked Ongoing Grade 2 - unchecked\nA\nRECURRENT URINARY\n20 UN UNK 2021 unchecked Resolved - 17 AUG 2021 unchecked\nTRACT INFECTIONS REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nConcomitant Medication\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nCOVID PROPHYLA INJECTIO Intramusc 02 MAR unchecke 30 MAR\n1 VACCINE - Prophylaxis XIS - - 1 Other N Q4wk - ular - 2021 d 2021 unchecked\nMODERNA INFECTION\nVALACYCLO PROPHYLA 26 OCT unchecke\n2 VIR Prophylaxis XIS - - 500 mg - BID - Oral - 2020 d - checked\nINFECTION\nTRIMETHOP PROPHYLA 16 AUG unchecke\n3 RIM Prophylaxis XIS - - 100 mg - QD - Oral - 2021 d - checked\nURINARY\nMedical 17_INSOM 18 AUG unchecke\n4 MELATONIN History - NIA_17 - 6 mg - PRN - Oral - 2021 d - checked\nAUG 2021\nMETOPROL Medical 3_HYPERT 21 NOV unchecke\n5 OL History - ENSION_21 - 25 mg - QD - Oral - 2016 d - checked\nNOV 2016\nGUAIFENES Medical 10_COUGH 19 AUG unchecke\n6 IN History - _12 AUG - 10 mL - PRN - Oral - 2021 d - checked\n2021\nFUROSEMID Medical 12_INTERM Intraveno 17 AUG unchecke 17 AUG\n7 E History - ITTENT - 40 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nFUROSEMID Medical 12_INTERM Intraveno 19 AUG unchecke 19 AUG\n8 E History - ITTENT - 20 mg - QD - us - 2021 d 2021 unchecked\nFLUID\nAZITHROMY Medical 18_FEVER_ 19 AUG unchecke 19 AUG\n9 CIN History - 15 AUG - 500 mg - QD - Oral - 2021 d 2021 unchecked\n2021\nPROPHYLA 17 AUG unchecke 17 AUG\n10 MORPHINE Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPROPHYLA 17 AUG unchecke 17 AUG\n11 MIDAZOLAM Prophylaxis - - 5 mg - QD - Oral - unchecked\nXIS PAIN 2021 d 2021\nPAMIDRON Medical 2_HYPERC Intraveno 16 AUG unchecke 16 AUG\n12 ATE History - ALCEMIA_1 - 90 mg - QD - us - 2021 d 2021 unchecked\n2 AUG 2021 REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nPOTASSIUM Medical 8_INTERMI Intraveno 18 AUG unchecke 18 AUG\n13 CHLORIDE History - TTENT - 30 mEq - QD - us - 2021 d 2021 unchecked\nER HYPOKALE\nSODIUM Medical 9_INTERMI 17 AUG unchecke 18 AUG\n14 AND History - TTENT - 500 mg - QD - Oral - 2021 d 2021 unchecked\nPOTASSIUM HYPOPHO\nSODIUM Medical 9_INTERMI 19 AUG unchecke\n15 AND History - TTENT - 500 mg - BID - Oral - 2021 d - checked\nPOTASSIUM HYPOPHO\nPOTASSIUM Medical 8_INTERMI Intraveno 17 AUG unchecke\n16 CHLORIDE History - TTENT - 10 mEq - PRN - us - 2021 d - checked\nHYPOKALE\nACETAMINO Medical 18_FEVER_ 2_CYTOKIN 17 AUG unchecke\n17 PHEN History - 15 AUG E RELEASE 650 mg - PRN - Oral - 2021 d - checked\n2021 SYNDROM\nBENZONAT Medical 10_COUGH 19 AUG unchecke\n18 ATE History - _12 AUG - 100 mg - PRN - Oral - 2021 d - checked\n2021\nAZITHROMY Medical 18_FEVER_ 20 AUG unchecke\n19 CIN History - 15 AUG - 250 mg - QD - Oral - 2021 d - checked\n2021\nPOTASSIUM Medical 8_INTERMI 20 AUG unchecke 20 AUG\n20 CHLORIDE History - TTENT - 30 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nALPRAZOLA PROPHYLA 20 AUG unchecke 20 AUG\n21 M Prophylaxis XIS - - 0.5 mg - QD - Oral - 2021 d 2021 unchecked\nPROCEDUR\nSODIUM Medical 9_INTERMI Intraveno 21 AUG unchecke 21 AUG\n22 PHOSPHAT History - TTENT - 15 Other MMOL QD - us - 2021 d 2021 unchecked\nE HYPOPHO\nPREDNISON Medical 18_FEVER_ 21 AUG unchecke\n23 E History - 15 AUG - 10 mg - QD - Oral - 2021 d - checked\n2021\nFLUCONAZ PROPHYLA 21 AUG unchecke\n24 OLE Prophylaxis XIS - - 200 mg - QD - Oral - 2021 d - checked\nINFECTION\nPOTASSIUM Medical 8_INTERMI 22 AUG unchecke 22 AUG\n25 CHLORIDE History - TTENT - 40 mEq - QD - Oral - 2021 d 2021 unchecked\nER HYPOKALE\nACETAMINO Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n26 PHEN Event - - E RELEASE 1000 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM\nTOCILIZUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n27 AB Event - - E RELEASE 505.6 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nIf If\nIndication Indication\nis medical is adverse\nIf history, event,\nStart date Stop date\nProphylaxis Please Please Dose Other, If Other If Other, Start\n# Drug Name Indication Dose Frequency Route (dd-mon- (dd-mon- Ongoing\nOr Other, select the select the Unit specify Specify specify Date Unk\nyyyy) yyyy)\nspecify appropriate appropriate\nMedical Adverse\nHistory Event\nrecord. record.\nSODIUM Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n28 CHLORIDE Event - - E RELEASE 1000 mL - QD - us - 2021 d 2021 unchecked\n0.9% SYNDROM\nDEXAMETH Adverse 5_CYTOKIN Intraveno 01 SEP unchecke 01 SEP\n29 ASONE Event - - E RELEASE 10 mg - QD - us - 2021 d 2021 unchecked\nSYNDROM REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nBlood Chemistry - Local Lab\nIf at\ndosing\nWas a Date of visit, was Blood Aspartate Alanine\nReason Glucose\nInstance Sample Other, Collection the Potassiu Total Creatini urea Aminotran Aminotran\nNot Sodium Chloride Calcium (Non- Albumin Urea\nName Collecte Specify (dd-mon- sample m Protein ne nitrogen sferase sferase\nDone Fasting)\nd? yyyy) collected (BUN) (AST) (ALT)\nprior to\ndosing?\nNot\nSCREE 16 AUG 138_mE 3.3_mE 108_mE 13_mg/ 83_mg/ 3.9_g/ 5.6_g/ 1.5_mg/ 24_mg/\nYes - - Applicabl _mg/dL 27_U/L 34_U/L\nNING 2021 q/L q/L q/L dL dL dL dL dL dL\ne REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAlkali Creatini\nGamma- Correcte\nAlanine ne Lactate Phosph Creatine Triglyce ne\nCreatine glutamyl d Serum\nAminotran Phos Dehydro Total Direct Instance Uric orus phosph rides Bicarbo Carbon Clearan\nKinase transfer Calcium\nsferase phata genase Bilirubin bilirubin Name Acid (Phosph okinase (non- nate dioxide ce\n(CK) ase (derived\n(ALT) se (LDH) ate) (CPK) fasting) (derived\n(GGT) )\n(ALP) )\n178_ 209_U/ 0.4_mg/ 0.2_mg/ SCREE 4.4_mg/ 2.9_mg/ 158_U/ 132_mg 20_mEq\n34_U/L _ 13_U/L _mEq/L 3.26 38.25\nU/L L dL dL NING dL dL L /dL /L REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Events\nIf outcome\nis\nAE AE\nMain Recovered\nSelect if suspected suspected If yes,\nAdverse Start date /Resolved Resolution\nAE is to be to be specify Outcome\n # Event (dd-mon- with date (dd-\nintermitten caused by caused by study of AE\nDescriptio yyyy) Sequelae; mon-yyyy)\nt REGN1979 study conduct\nn (Term) Specify\n? conduct?\nthe\nsequelae.\nINFUSION\n21 SEP Recovered/ 22 SEP\n6 RELATED - Yes No - -\n2021 Resolved 2021\nREACTION REG-2021-00131 GSPV RECEIPT DATE 22SEP2021 AKA 25 pages\nAdverse Event Details\nAE initial severity grade Grade 2\nAE most extreme severity grade Grade 2\nDate event Became Grade 3 or higher - if applicable\n(dd-mon-yyyy)\nDate event became higher than Grade 3 - Not applicable 1\nDate event became lesser than Grade 3 - Not applicable\nAction taken with REGN1979 Dose Not Changed\nDoes this AE qualify as Serious? Yes\nIs this an AE of Special interest (AESI)? No\nSeriouness Criteria\nIt resulted in death No\nIt was life-threatening No\nIt required or prolonged inpatient hospitalization Yes\nPersistent or significant disability / incapacity No\nIt is a congenital anomaly/birth defect in offspring of\nNo\nstudy subject\nOther medically serious important event No']
apiLogger::2021-11-05 14:47:56,470::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-11-05 14:47:56,470::structured_code.py::(line:19)::struct_parser()::INFO : Content type is REGN_1625
apiLogger::2021-11-05 14:47:56,470::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-11-05 14:47:56,470::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-11-05 14:47:56,470::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-11-05 14:48:16,641::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-11-05 14:48:16,641::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 16:41:57,660::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 16:41:57,666::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 16:41:57,666::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmp30jvgmzt 
apiLogger::2021-11-05 16:41:57,667::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 16:41:57,667::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 16:41:57,804::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 16:41:57,804::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmp30jvgmzt
apiLogger::2021-11-05 16:42:00,719::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 16:42:00,719::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 16:42:00,720::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 16:42:00,720::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 16:42:00,724::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-05 16:42:00,724::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 16:42:00,724::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-05 16:42:00,724::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-11-05 16:42:00,728::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-11-05 16:42:00,728::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-11-05 16:42:00,728::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-11-05 16:42:00,728::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-11-05 16:42:00,728::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 554002-Palmerston North Hospital\nEnvironment Prod\nSubject Details\nStudy Site Number 554,002\nPatient ID 554,002,977\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1949\nAge 71\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date 02 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? Yes\nDate patient signed Genomic Sub-study\nInformed Consent 25 MAR 2021\nWithdraw consent for Genomic Sub-Study? No\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 25 MAR 2021\nWithdraw consent for Future Biomedical\nResearch? No\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 25 MAR 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? Yes\nIf No, Date of Screen Failure\nReason for Screen Failure\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\n1_TYPE 2\nMedical DIABETES_UN JUN 06 APR\n1 METFORMIN History 2019 05 JAN 2021 No 2021 250 mg QD Oral\nMedical 3_INSOMNIA_UN JAN\n2 ZOPICLONE History 2021 11 FEB 2021 Yes 3.75 mg PRN Oral\nATORVASTA Medical 2_HYPERCHOLESTER\n3 TIN History OLEMIA_27 JAN 2019 07 JAN 2021 Yes 40 mg QD Oral\nPARACETMA Adverse 1_HEADACHE_3 31 MAR\n4 OL Event 1 MAR 2021 31 MAR 2021 No 2021 1 g QD Oral\nPARACETAM Adverse 2_ARTHRALGIA_14 21 APR\n5 OL Event APR 2021 14 APR 2021 No 2021 1 g BID Oral\nVARIBAR\nNECTOR VIDEOFLUR\nBARIUM OSCOPIC\nSULFATE SWALLOW 06 APR\n6 CONTRAST Other STUDY 06 APR 2021 No 2021 100 mL QD Oral\nNUTRITION\nAL\nSUPPLEME\n7 FORTISIP Other NT 20 JAN 2021 Yes 200 mL PRN Oral\nNUTRITION\nAL\nSUPPLEME\n8 ENSURE Other NT 20 JAN 2021 Yes 57 g PRN Oral\nPARACETAM Adverse 2_ARTHRALGIA_14\n9 OL Event APR 2021 20 MAY 2021 Yes 1 g QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08 09 JUN\n10 E Event JUN 2021 JUN 2021 09 JUN 2021 No 2021 60 mg QD Oral\n4_AST\nPREDNISON Adverse 3_ALT INCREASED_08 INCREASED_08\n11 E Event JUN 2021 JUN 2021 10 JUN 2021 Yes 60 mg BID Oral\nOMEPRAZOL\n12 E Prophylaxis GASTRIC ULCER 09 JUN 2021 Yes 20 mg QD Oral\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries? Yes\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nNERVE\nCONDUCTION AND\nELECTROMYOGRA\n1 PHY Medical History 20 APR 2021\nVIDEOFLUROSCOPI\nC SWALLOWING\n2 STUDY Medical History 06 APR 2021\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History? Yes\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\n1 TYPE 2 DIABETES UN JUN 2019 UNCHECKED Yes Grade 1 UNCHECKED\nHYPERCHOLESTERO\n2 LEMIA 27 JAN 2019 UNCHECKED Yes Grade 1 UNCHECKED\n3 INSOMNIA UN JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n4 XEROSTOMIA 19 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\nNEUROPRAXIA LEFT\n5 ULNAR NERVE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT VOCAL FOLD\nPARALYSIS\nSECONDARY TO\nVAGAL NERVE\n6 SACRIFICE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n7 FATIGUE 02 FEB 2021 UNCHECKED Yes Grade 1 UNCHECKED\n8 WATERING LEFT EYE 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\n9 HYPERTENSION 24 MAY 2020 UNCHECKED No CHECKED\nRIGHT ANKLE JOINT\nSURGERIES AND\n10 ARTHRODESIS CHECKED No CHECKED\nRIGHT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n11 CEMENT UN JAN 2015 UNCHECKED No CHECKED\nRIGHT SHOULDER\n12 RECONSTRUCTION UN NOV 2018 UNCHECKED No CHECKED\nNON ALCOHOLIC\n13 FATTY LIVER UN FEB 2001 UNCHECKED Yes Grade 1 UNCHECKED\n14 HEARING LOSS 27 JAN 2019 UNCHECKED Yes Grade 2 UNCHECKED\nLEFT TOTAL\nPROSTHETIC KNEE\nREPLACEMENT AND\n15 CEMENT UN MAR 2017 UNCHECKED No CHECKED\nISCHAEMIC HEART\n16 DISEASE UN JUL 2019 UNCHECKED Yes Grade 1 UNCHECKED\n17 TONSILLECTOMY UN JAN 1970 UNCHECKED No CHECKED\nIRREGULAR BOWEL\n18 MOTIONS 17 NOV 2020 UNCHECKED Yes Grade 2 UNCHECKED\nPEG FEEDING TUBE\n19 INSERTION 18 JAN 2021 UNCHECKED No 18 JAN 2021 UNCHECKED\nALLERGY TO\n20 PENICILLIN CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n21 TRAMADOL CHECKED Yes Unknown UNCHECKED\nALLERGY TO\n22 LISINOPRIL CHECKED Yes Unknown UNCHECKED\nCUTANEOUS\nABSCESS LEFT\nPREAURICULAR\n23 AREA 03 JUL 2020 UNCHECKED No 04 JUL 2020 UNCHECKED\n24 ANAEMIA 20 JAN 2021 UNCHECKED Yes Grade 1 UNCHECKED\n25 TRISMUS 17 NOV 2020 UNCHECKED No 19 MAY 2021 UNCHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type: HN CSCC\nDate of Initial Diagnosis 20 APR 2020\nStage Based on Surgical Pathology Stage IV\nT T3\nN N2b\nM M0\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm UNCHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC CHECKED\n≥N2b disease associated with the recurrent lesion CHECKED\nNominal ≥T3 CHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion CHECKED\nR2810-ONC-1788_SAE REPORT_15-JUN-2021']
apiLogger::2021-11-05 16:42:00,729::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-11-05 16:42:00,729::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-11-05 16:42:00,729::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-11-05 16:42:00,729::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-11-05 16:42:00,729::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-11-05 16:42:19,699::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-11-05 16:42:19,699::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
apiLogger::2021-11-05 18:41:34,788::run_pvi_api.py::(line:47)::call_main()::INFO : ********** NEW PARSING STARTS HERE **********

apiLogger::2021-11-05 18:41:34,793::pvi_api.py::(line:45)::init_dir()::INFO : creating temp directories
apiLogger::2021-11-05 18:41:34,793::pvi_api.py::(line:59)::init_dir()::INFO : Successfully created the directory /tmp/tmpbiwsp5ql 
apiLogger::2021-11-05 18:41:34,794::content_type.py::(line:93)::find_content_type()::DEBUG : inside content type try catch
apiLogger::2021-11-05 18:41:34,794::content_type.py::(line:95)::find_content_type()::INFO : opening file in content type
apiLogger::2021-11-05 18:41:34,905::content_type.py::(line:97)::find_content_type()::INFO : done with openpdf in content type
apiLogger::2021-11-05 18:41:34,905::content_type.py::(line:98)::find_content_type()::DEBUG : extracting data from file in content type .py/tmp/tmpbiwsp5ql
apiLogger::2021-11-05 18:41:36,777::content_type.py::(line:110)::find_content_type()::DEBUG : **done with extracting data from form in content type********************************************************
apiLogger::2021-11-05 18:41:36,777::content_type.py::(line:123)::find_content_type()::DEBUG : after finding digital text
apiLogger::2021-11-05 18:41:36,777::content_type.py::(line:124)::find_content_type()::INFO : test_digital = TF _______________________
apiLogger::2021-11-05 18:41:36,777::content_type.py::(line:131)::find_content_type()::DEBUG : i is 0
apiLogger::2021-11-05 18:41:36,781::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeUNKNOWN
apiLogger::2021-11-05 18:41:36,781::content_type.py::(line:134)::find_content_type()::DEBUG : main: 0
apiLogger::2021-11-05 18:41:36,781::content_type.py::(line:178)::find_content_type()::DEBUG : outside:1
apiLogger::2021-11-05 18:41:36,781::content_type.py::(line:131)::find_content_type()::DEBUG : i is 1
apiLogger::2021-11-05 18:41:36,785::content_type.py::(line:133)::find_content_type()::INFO : discovered content typeRGN_1788
apiLogger::2021-11-05 18:41:36,785::content_type.py::(line:134)::find_content_type()::DEBUG : main: 1
apiLogger::2021-11-05 18:41:36,785::content_type.py::(line:136)::find_content_type()::DEBUG : inside not unknown
apiLogger::2021-11-05 18:41:36,785::content_type.py::(line:142)::find_content_type()::DEBUG : inside: 1
apiLogger::2021-11-05 18:41:36,786::pvi_api.py::(line:221)::main_function()::DEBUG : ['RGN_1788', 'generic', 'Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nProject Details\nProject Name R2810-ONC-1788\nICON Study Code 0456/0232\nSite Name 036018-RIVERINA CANCER CARE CENTRE\nEnvironment Prod\nSubject Details\nStudy Site Number 36,018\nPatient ID\n46,018,00397\nHas the subject been rescreened within the\nsame protocol? No\nIf Yes, previous Subject ID\nDemography Details\nYear of birth 1944\nAge 77\nSex Male\nEthnicity Not Hispanic or Latino\nRace (choose only one primary race) White\nIf Other, specify:\nIs the patient of childbearing potential?\nIf No, please specify reason:\nRandomization Details\nRandomization Date\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 1 Details\nConsent for Genomic Sub-Study obtained? No\nDate patient signed Genomic Sub-study\nInformed Consent\nWithdraw consent for Genomic Sub-Study?\nDate Genomics Sub-Study Consent\nWithdrawn\nConsent for Future Biomedical Research\nobtained? Yes\nDate patient signed Future Biomedical\nResearch Informed Consent 20 AUG 2021\nWithdraw consent for Future Biomedical\nResearch?\nDate Future Biomedical Research consent\nwithdrawn\nDate Patient signed Informed Protocol version in effect at time of\nRecordPosition Consent Form informed consent\n1 20 AUG 2021 Amendment 1\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nInformed Consent for Part 2 Details\nDate Patient signed\nInformed Consent Protocol version in effect at\nRecordPosition Form for Part 2 time of informed consent\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 1 details\nIs the patient eligible for this study? No\nIf No, Date of Screen Failure 08 SEP 2021\nReason for Screen Failure Withdrawn consent\nIf reason is Other, specify:\nIf Eligibility Criteria not met, specify\nRecordPosition Criteria Number criteria\n1 Inclusion PATIENT WITHDREW\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nSubject Eligibility - Part 2 details\nIs the patient eligible for Part 2?\nNo documentation of disease recurrence UNCHECKED\nNo separate informed consent for\ncemiplimab treatment in Part 2 UNCHECKED\nPrior study drug treatment was\ndiscontinued due to unacceptable toxicity UNCHECKED\nOther UNCHECKED\nIf reason is Other, specify:\nIf reason is Eligibility Criteria\nRecordPosition not met, specify the criteria Criteria Number\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Medications details\nHas the Patient received any prior and/or concomitant\nmedication? Yes\nIf Indication is medical\nIf Indication is history, Please select If for prophylaxis,\nadverse event, Please the appropriate please specify which Is Concomitant\nRecordPositio Medication select the appropriate Adverse Event Adverse Event Adverse Event Adverse Event Medical History Medical Medical Medical Medical condition this is used If Other, Medication If Other,\nn Name Indication Adverse Event record. #2 #3 #4 #5 record. History #2 History #3 History #4 History #5 for specify: Start Date ongoing? Stop Date Dose Dose unit If Other, specify: Frequency specify: Route If Other, specify:\nFLUCONAZO Adverse 1_SEPSIS_23 AUG\n1 LE Event 2021 20 AUG 2021 Yes 100 mg QD Oral\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nConcomitant Procedures/Surgeries details\nHas the Patient had any procedures or\nsurgeries?\nReason for surgery/ Date of concomitant\nRecordPosition Procedure / Surgery procedure If Other, specify: procedure/surgery\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nMedical History details\nDoes Patient have any Medical History?\nCheck for unknown start Ongoing at study If Ongoing Specify Check for\nRecordPosition Disorder/Diagnosis Start Date date entry? CTCAE Grade Stop Date unknown end date\nUNCHECKED UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021 Regeneron Pharmaceuticals Inc. \nSerious Adverse Events (SAE) Form\nCSCC Diagnosis and History details\nTumor Type:\nDate of Initial Diagnosis\nStage Based on Surgical Pathology\nT\nN\nM\nNodal disease with extracapsular extension (ECE)\nand at least 1 node >20 mm CHECKED\nIn-transit metastases UNCHECKED\nT4 lesion UNCHECKED\nPerineural invasion UNCHECKED\nFacial nerve (cranial nerve VII) UNCHECKED\nTrigeminal nerve (cranial nerve V) UNCHECKED\nOther, specify named nerve:\nRecurrent CSCC UNCHECKED\n≥N2b disease associated with the recurrent lesion UNCHECKED\nNominal ≥T3 UNCHECKED\nPoorly differentiated histology and ≥20 mm diameter\nof recurrent lesion UNCHECKED\nR2810-ONC-1788_SAE REPORT_20-SEP-2021']
apiLogger::2021-11-05 18:41:36,786::structured_code.py::(line:15)::struct_parser()::INFO : parsing structured form
apiLogger::2021-11-05 18:41:36,786::structured_code.py::(line:19)::struct_parser()::INFO : Content type is RGN_1788
apiLogger::2021-11-05 18:41:36,786::structured_code.py::(line:20)::struct_parser()::INFO : Module name is generic
apiLogger::2021-11-05 18:41:36,786::structured_code.py::(line:21)::struct_parser()::DEBUG : going for if condition
apiLogger::2021-11-05 18:41:36,786::structured_code.py::(line:31)::struct_parser()::DEBUG : ModuleSpec(name='py_generic', loader=<_frozen_importlib_external.SourceFileLoader object at 0x7f6d58900048>, origin='/home/ubuntu/pvi-form-engine/structuredForms/py_generic/__init__.py', submodule_search_locations=['/home/ubuntu/pvi-form-engine/structuredForms/py_generic'])
apiLogger::2021-11-05 18:41:51,099::structured_code.py::(line:49)::struct_parser()::INFO : completed parsing in generic
apiLogger::2021-11-05 18:41:51,099::pvi_api.py::(line:73)::flush_dir()::INFO : now cleaning temp directories
